← Back to Search

Zavegepant for Asthma

Phase 1
Waitlist Available
Research Sponsored by Biohaven Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-7 hours
Awards & highlights

Study Summary

This trial is testing whether an active drug is better than a placebo at treating asthma. The trial is double-blind, meaning that neither the participants nor the researchers will know who is receiving the active drug or the placebo. The trial is also randomized, meaning that participants will be assigned to either the active drug or the placebo group by chance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-7 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-7 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Allergen induced late asthmatic response (LAR)

Side effects data

From 2021 Phase 3 trial • 1978 Patients • NCT04571060
21%
Dysgeusia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Zavegepant 10 mg
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BHV3500Experimental Treatment1 Intervention
Zavegepant 150 mg BID
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo 150 mg BID
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zavegepant
2019
Completed Phase 3
~4150

Find a Location

Who is running the clinical trial?

Biohaven Pharmaceuticals, Inc.Lead Sponsor
47 Previous Clinical Trials
37,237 Total Patients Enrolled
PfizerLead Sponsor
4,580 Previous Clinical Trials
14,634,188 Total Patients Enrolled
39 Trials studying Asthma
62,120 Patients Enrolled for Asthma
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,485 Previous Clinical Trials
11,811,063 Total Patients Enrolled
16 Trials studying Asthma
1,019 Patients Enrolled for Asthma
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top